A novel targeted therapy provided an incremental improvement in response rate among breast cancer patients with poor prognoses — those with heavily pretreated metastatic triple-negative breast cancer (TNBC).
Medscape Medical News …read more
A novel targeted therapy provided an incremental improvement in response rate among breast cancer patients with poor prognoses — those with heavily pretreated metastatic triple-negative breast cancer (TNBC).
Medscape Medical News …read more